Aplindore
id:
aplindore-303-18459988
title:
Aplindore
text:
Aplindore (DAB-452) is a drug which acts as a partial agonist selective for the dopamine receptor D2. It is being developed by the pharmaceutical company Neurogen as a treatment for Parkinson's disease and restless legs syndrome. On December 23, 2009 Neurogen was acquired by Ligand Pharmaceuticals. Rights to Aplindore were given to Ligand around time of merger. As of 2008, Phase II was completed and Ligand. Upon reviewing company website (Ligand.com) this drug is currently not listed at the mome
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Aplindore
date created:
date modified:
2022-11-13T20:14:38Z
main entity:
{"identifier":"Q106271348","url":"https://www.wikidata.org/entity/Q106271348"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/2/2d/Aplindore_Structure.svg","width":512,"height":230}
fields total:
13
integrity:
15